BioCentury | Dec 12, 2020
Translation in Brief
Fecal transplant improves checkpoint inhibitor response in Phase I; plus Secarna’s antitumor antisense oligos, a blood-based mRNA test for Alzheimer’s and more
...cancer. The data from the study, done in collaboration with researchers from Princeton University and Firebrand Therapeutics Inc....
...B7-H1; CD274) – Programmed cell death 1 ligand 1 PGE2 – Prostaglandin E2 Danielle Golovin Secarna Pharmaceuticals GmbH Princeton University Firebrand Therapeutics Inc. Stanford...
...B7-H1; CD274) – Programmed cell death 1 ligand 1 PGE2 – Prostaglandin E2 Danielle Golovin Secarna Pharmaceuticals GmbH Princeton University Firebrand Therapeutics Inc. Stanford...
